EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ:ATRS) today announced that a meeting was held with the U.S. Food and Drug Administration (FDA) to discuss a registration study for the VIBEX ...

Every item on this page was chosen by an ELLE editor. We may earn commission on some of the items you choose to buy. For those who need it—men who have low levels of testosterone with symptoms such as ...